Cargando…
Dexmedetomidine Protects against Airway Inflammation and Airway Remodeling in a Murine Model of Chronic Asthma through TLR4/NF-κB Signaling Pathway
Asthma is a common respiratory disease characterized by chronic airway inflammation. Dexmedetomidine (DEX), a highly selective α2 adrenergic receptor agonist, has been shown to participate in regulating inflammatory states and thus exert organ protective actions. However, the potential of DEX in ast...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946744/ https://www.ncbi.nlm.nih.gov/pubmed/36846195 http://dx.doi.org/10.1155/2023/3695469 |
_version_ | 1784892398834286592 |
---|---|
author | Zhou, Ying Du, Xiyu Wang, Qianyu Xiao, Shilin Zhi, Juan Gao, Huibin Yang, Dong |
author_facet | Zhou, Ying Du, Xiyu Wang, Qianyu Xiao, Shilin Zhi, Juan Gao, Huibin Yang, Dong |
author_sort | Zhou, Ying |
collection | PubMed |
description | Asthma is a common respiratory disease characterized by chronic airway inflammation. Dexmedetomidine (DEX), a highly selective α2 adrenergic receptor agonist, has been shown to participate in regulating inflammatory states and thus exert organ protective actions. However, the potential of DEX in asthma is still unknown. This study is aimed at investigating the role of DEX in a mouse model of house dust mite- (HDM-) induced asthma and exploring its underlying mechanism. Here, we found that DEX treatment significantly ameliorated airway hyperresponsiveness, airway inflammation, and airway remodeling in the asthmatic mice, which were similar to the efficacy of the reference anti-inflammatory drug dexamethasone. In addition, DEX reversed the increased expression of toll-like receptor 4 (TLR4) and its downstream signaling adaptor molecule nuclear factor-κB (NF-κB) in the lung tissue of asthmatic mice. Furthermore, these protective effects of DEX were abolished by yohimbine, an α2 adrenergic receptor antagonist. These results indicate that DEX is capable of ameliorating airway inflammation and remodeling in asthmatic mice, and this protective effect is associated with the inhibition of the TLR4/NF-κB signaling pathway. |
format | Online Article Text |
id | pubmed-9946744 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-99467442023-02-23 Dexmedetomidine Protects against Airway Inflammation and Airway Remodeling in a Murine Model of Chronic Asthma through TLR4/NF-κB Signaling Pathway Zhou, Ying Du, Xiyu Wang, Qianyu Xiao, Shilin Zhi, Juan Gao, Huibin Yang, Dong Mediators Inflamm Research Article Asthma is a common respiratory disease characterized by chronic airway inflammation. Dexmedetomidine (DEX), a highly selective α2 adrenergic receptor agonist, has been shown to participate in regulating inflammatory states and thus exert organ protective actions. However, the potential of DEX in asthma is still unknown. This study is aimed at investigating the role of DEX in a mouse model of house dust mite- (HDM-) induced asthma and exploring its underlying mechanism. Here, we found that DEX treatment significantly ameliorated airway hyperresponsiveness, airway inflammation, and airway remodeling in the asthmatic mice, which were similar to the efficacy of the reference anti-inflammatory drug dexamethasone. In addition, DEX reversed the increased expression of toll-like receptor 4 (TLR4) and its downstream signaling adaptor molecule nuclear factor-κB (NF-κB) in the lung tissue of asthmatic mice. Furthermore, these protective effects of DEX were abolished by yohimbine, an α2 adrenergic receptor antagonist. These results indicate that DEX is capable of ameliorating airway inflammation and remodeling in asthmatic mice, and this protective effect is associated with the inhibition of the TLR4/NF-κB signaling pathway. Hindawi 2023-02-15 /pmc/articles/PMC9946744/ /pubmed/36846195 http://dx.doi.org/10.1155/2023/3695469 Text en Copyright © 2023 Ying Zhou et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Zhou, Ying Du, Xiyu Wang, Qianyu Xiao, Shilin Zhi, Juan Gao, Huibin Yang, Dong Dexmedetomidine Protects against Airway Inflammation and Airway Remodeling in a Murine Model of Chronic Asthma through TLR4/NF-κB Signaling Pathway |
title | Dexmedetomidine Protects against Airway Inflammation and Airway Remodeling in a Murine Model of Chronic Asthma through TLR4/NF-κB Signaling Pathway |
title_full | Dexmedetomidine Protects against Airway Inflammation and Airway Remodeling in a Murine Model of Chronic Asthma through TLR4/NF-κB Signaling Pathway |
title_fullStr | Dexmedetomidine Protects against Airway Inflammation and Airway Remodeling in a Murine Model of Chronic Asthma through TLR4/NF-κB Signaling Pathway |
title_full_unstemmed | Dexmedetomidine Protects against Airway Inflammation and Airway Remodeling in a Murine Model of Chronic Asthma through TLR4/NF-κB Signaling Pathway |
title_short | Dexmedetomidine Protects against Airway Inflammation and Airway Remodeling in a Murine Model of Chronic Asthma through TLR4/NF-κB Signaling Pathway |
title_sort | dexmedetomidine protects against airway inflammation and airway remodeling in a murine model of chronic asthma through tlr4/nf-κb signaling pathway |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946744/ https://www.ncbi.nlm.nih.gov/pubmed/36846195 http://dx.doi.org/10.1155/2023/3695469 |
work_keys_str_mv | AT zhouying dexmedetomidineprotectsagainstairwayinflammationandairwayremodelinginamurinemodelofchronicasthmathroughtlr4nfkbsignalingpathway AT duxiyu dexmedetomidineprotectsagainstairwayinflammationandairwayremodelinginamurinemodelofchronicasthmathroughtlr4nfkbsignalingpathway AT wangqianyu dexmedetomidineprotectsagainstairwayinflammationandairwayremodelinginamurinemodelofchronicasthmathroughtlr4nfkbsignalingpathway AT xiaoshilin dexmedetomidineprotectsagainstairwayinflammationandairwayremodelinginamurinemodelofchronicasthmathroughtlr4nfkbsignalingpathway AT zhijuan dexmedetomidineprotectsagainstairwayinflammationandairwayremodelinginamurinemodelofchronicasthmathroughtlr4nfkbsignalingpathway AT gaohuibin dexmedetomidineprotectsagainstairwayinflammationandairwayremodelinginamurinemodelofchronicasthmathroughtlr4nfkbsignalingpathway AT yangdong dexmedetomidineprotectsagainstairwayinflammationandairwayremodelinginamurinemodelofchronicasthmathroughtlr4nfkbsignalingpathway |